Importer of Controlled Substances; Notice of Application, 33784-33785 [2011-14255]

Download as PDF 33784 Federal Register / Vol. 76, No. 111 / Thursday, June 9, 2011 / Notices following meeting. Earlier announcement of this meeting was not possible. By order of the Commission: Issued: June 7, 2011. James R. Holbein, Secretary to the Commission. [FR Doc. 2011–14471 Filed 6–7–11; 4:15 pm] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE mstockstill on DSK4VPTVN1PROD with NOTICES Notice of Lodging of Consent Decree Under the Comprehensive Environmental Response, Compensation and Liability Act (CERCLA) Pursuant to Section 122 of the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended (‘‘CERCLA’’), 42 U.S.C. 9622, notice is hereby given that on May 31, 2011, a proposed Consent Decree in United States v. United Nuclear Corporation, No. CV 11– 01060–PHX–NVW (D. Ariz.), was lodged with the United States District Court for the District of Arizona with respect to the Pine Mountain Mine Site (‘‘Site’’) located in the Tonto National Forest in Arizona. On May 27, 2011, the United States, on behalf of the U.S. Department of Agriculture, Forest Service (‘‘Forest Service’’), filed a Complaint in this matter against defendant United Nuclear Corporation (‘‘UNC’’) pursuant to CERCLA Section 107, 42 U.S.C. 9607, for environmental response costs incurred or to be incurred by the Forest Service to address releases or threatened releases of hazardous substances at the Site. The proposed Consent Decree resolves the claims in the Complaint. Under the Consent Decree, UNC will pay the Forest Service $800,000 in reimbursement of response costs. In return, UNC and certain of its corporate affiliates receive a covenant not to sue or to take administrative action pursuant to Sections 106 and 107 of CERCLA, 42 U.S.C. 9606 and 9607, from the United States with respect to certain response costs and response actions, including the costs of, and performance by, the Forest Service of a removal action at the Site to address the mercury and other hazardous substances present in the mining wastes and sediments at the Site. The Department of Justice will receive for a period of thirty (30) days from the date of this publication comments relating to the proposed Settlement Agreement. Comments should be addressed to the Assistant Attorney VerDate Mar<15>2010 17:56 Jun 08, 2011 Jkt 223001 General, Environment and Natural Resources Division, and either e-mailed to pubcomment-ees.enrd@usdoj.gov or mailed to P.O. Box 7611, U.S. Department of Justice, Washington, DC 20044–7611, and should refer to United States v. United Nuclear Corporation, No. CV 11–01060–PHX–NVW (D. Ariz.), D.J. Ref. 90–11–3–07803/1. During the public comment period, the proposed Consent Decree may also be examined on the following Department of Justice Web site: https:// www.usdoj.gov/enrd/ Consent_Decrees.html. A copy of the proposed Consent Decree may also be obtained by mail from the Consent Decree Library, P.O. Box 7611, U.S. Department of Justice, Washington, DC 20044–7611 or by faxing or e-mailing a request to Tonia Fleetwood (tonia.fleetwood@usdoj.gov), fax no. (202) 514–0097, phone confirmation number (202) 514–1547. In requesting a copy from the Consent Decree Library, please enclose a check in the amount of $6.25 (25 cents per page reproduction cost) payable to the U.S. Treasury or, if by e-mail or fax, forward a check in that amount to the Consent Decree Library at the stated address. mitigate the damages and to pay a civil penalty. The Department of Justice will accept written comments relating to this proposed Consent Decree for thirty (30) days from the date of publication of this Notice. Please address comments to David A. Carson, United States Department of Justice, Environment and Natural Resources Division, 999 18th Street, South Terrace, Suite 370, Denver, Colorado, 80202, and refer to United States v. Candle Development, LLC, DJ# 90–5–1–1–17957. The proposed Consent Decree may be examined at the Clerk’s Office, United States District Court for the District of South Dakota, Southern Division. In addition, the proposed Consent Decree may be viewed at https://www.usdoj.gov/ enrd/Consent_Decrees.html. Henry Friedman, Assistant Chief, Environmental Enforcement Section, Environment and Natural Resources Division. Importer of Controlled Substances; Notice of Application [FR Doc. 2011–14323 Filed 6–8–11; 8:45 am] BILLING CODE 4410–15–P DEPARTMENT OF JUSTICE Notice of Lodging Proposed Consent Decree In accordance with Departmental Policy, 28 CFR 50.7, notice is hereby given that a proposed Consent Decree in United States v. Candle Development, LLC, Case No. 08–4086, was lodged with the United States District Court for the District of South Dakota, Southern Division, on June 3, 2011. This proposed Consent Decree concerns a complaint filed by the United States against Candle Development, LLC, pursuant to Sections 301, 309, and 404 of the Clean Water Act, 33 U.S.C. 1311, 1319, and 1344, to obtain injunctive relief from and impose civil penalties against the Defendants for violating the Clean Water Act by, among other things, discharging pollutants without a permit into waters of the United States. The proposed Consent Decree resolves these allegations by requiring the Defendants to restore the impacted areas and/or PO 00000 Frm 00085 Fmt 4703 Sfmt 4703 Cherie Rogers, Assistant Section Chief, Environmental Defense Section, Environment & Natural Resources Division. [FR Doc. 2011–14234 Filed 6–8–11; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in Schedule I or II, and prior to issuing a regulation under 21 U.S.C. 952(a)(2) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing. Therefore, in accordance with 21 CFR 1301.34(a), this is notice that on March 25, 2011, AllTech Associates Inc., 2051 Waukegan Road, Deerfield, Illinois 60015, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the following basic classes of controlled substances: Drug Gamma Hydroxybutyric Acid (2010). Lysergic acid diethylamide (7315) Heroin (9200) ............................... Cocaine (9041) ............................. Codeine (9050) ............................. Hydrocodone (9193) ..................... Meperidine (9230) ........................ Methadone (9250) ........................ Morphine (9300) ........................... E:\FR\FM\09JNN1.SGM 09JNN1 Schedule I I I II II II II II II Federal Register / Vol. 76, No. 111 / Thursday, June 9, 2011 / Notices The company plans to import these controlled substances for the manufacture of reference standards. Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substances may file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43, and in such form as prescribed by 21 CFR 1316.47. Any such written comments or objections should be addressed, in quintuplicate, to Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than July 11, 2011. This procedure is to be conducted simultaneously with, and independent of, the procedures described in 21 CFR 1301.34(b), (c), (d), (e), and (f). As noted in a previous notice published in the Federal Register on September 23, 1975, 40 FR 43745–46, all applicants for registration to import a basic class of any controlled substance in Schedule I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied. Drug I I Any such comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than August 8, 2011. I I I I Dated: June 1, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. Schedule Manufacturer of Controlled Substances; Notice of Application Methcathinone (1237) .................. N-ethylamphetamine (1475) ......... N,N-dimethylamphetamine (1480) 4-methylaminorex (cis isomer) (1590). Alpha-ethyltryptamine (7249) ....... Lysergic acid diethylamide (7315) 2,5-dimethoxy-4-(n)propylthiophenethylamine. (7348) ........................................... Tetrahydrocannabinols (7370) ..... Mescaline (7381) .......................... 4-bromo-2,5-dimethoxy-amphetamine (7391). 4–Bromo-2,5dimethoxyphenethylamine (7392). 4-methyl-2,5-dimethoxy-amphetamine (7395). 2,5-dimethoxyamphetamine (7396). 2,5-dimethoxy-4ethylamphetamine (7399). 3,4-methylenedioxy amphetamine (7400). N-hydroxy-3,4methylenedioxyamphetamine (7402). 3,4-methylenedioxy-Nethylamphetamine (7404). 3,4methylenedioxymethamphetamine (MDMA) (7405). 4-methoxyamphetamine (7411) ... Alpha-methyltryptamine (7432) .... Bufotenine (7433) ......................... Diethyltryptamine (7434) .............. Dimethyltryptamine (7435) ........... Psilocybin (7437) .......................... Psilocyn (7438) ............................. 5-methoxy-N,Ndiisopropyltryptamine (7439). N-ethyl-1-phenylcyclohexylamine (7455). 1-(1-phenylcyclohexyl)-pyrrolidine (7458). 1-[1-(2-thienyl)-cyclohexyl]-piperidine (7470). Dihydromorphine (9145) ............... Normorphine (9313) ..................... Methamphetamine (1105) ............ 1-phenylcyclohexylamine (7460) .. Phencyclidine (7471) .................... Phenylacetone (8501) .................. 1-piperidinocyclohexanecarbonitrile (8603). Cocaine (9041) ............................. Codeine (9050) ............................. Dihydrocodeine (9120) ................. Ecgonine (9180) ........................... Meperidine intermediate-B (9233) Noroxymorphone (9668) .............. Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on March 28, 2011, Alltech Associates Inc., 2051 Waukegan Road, Deerfield, Illinois 60015, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: The company plans to manufacture high purity drug standards used for analytical applications only in clinical, toxicological, and forensic laboratories. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR § 1301.33(a). Dated: June 1, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2011–14255 Filed 6–8–11; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE mstockstill on DSK4VPTVN1PROD with NOTICES Drug Enforcement Administration VerDate Mar<15>2010 19:07 Jun 08, 2011 Jkt 223001 PO 00000 Frm 00086 Fmt 4703 Sfmt 4703 33785 I I I I [FR Doc. 2011–14253 Filed 6–8–11; 8:45 am] I BILLING CODE 4410–09–P I DEPARTMENT OF JUSTICE I Federal Bureau of Investigation I Notice of Charter Reestablishment I In accordance with the provisions of the Federal Advisory Committee Act, Title 5, United States Code, Appendix, and Title 41, Code of Federal Regulations, Section 101–6.1015, with the concurrence of the Attorney General, I have determined that the reestablishment of the Criminal Justice Information Services (CJIS) Advisory Policy Board (APB) is in the public interest. In connection with the performance of duties imposed upon the FBI by law, I hereby give notice of the reestablishment of the APB Charter. The APB provides me with general policy recommendations with respect to the philosophy, concept, and operational principles of the various criminal justice information systems managed by the FBI’s CJIS Division. The APB includes representatives from local and state criminal justice agencies; Tribal law enforcement representatives; members of the judicial, prosecutorial, and correctional sectors of the criminal justice community, as well as one individual representing a national security agency; a representative of Federal agencies participating in the CJIS Division Systems; and representatives of criminal justice professional associations (i.e., the American Probation and Parole Association; American Society of Crime Laboratory Directors, Inc.; International Association of Chiefs of Police; National District Attorneys’ Association; National Sheriffs’ Association; Major Cities Chiefs’ Association; Major County Sheriffs’ Association; and a representative from a national professional association representing the courts or court administrators nominated by the Conference of Chief Justices). The Attorney General has I I I I I I I I I I I I I I I I II II II II II II II II II II II E:\FR\FM\09JNN1.SGM 09JNN1

Agencies

[Federal Register Volume 76, Number 111 (Thursday, June 9, 2011)]
[Notices]
[Pages 33784-33785]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-14255]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application

    Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to 
issuing a registration under this Section to a bulk manufacturer of a 
controlled substance in Schedule I or II, and prior to issuing a 
regulation under 21 U.S.C. 952(a)(2) authorizing the importation of 
such a substance, provide manufacturers holding registrations for the 
bulk manufacture of the substance an opportunity for a hearing.
    Therefore, in accordance with 21 CFR 1301.34(a), this is notice 
that on March 25, 2011, AllTech Associates Inc., 2051 Waukegan Road, 
Deerfield, Illinois 60015, made application by renewal to the Drug 
Enforcement Administration (DEA) to be registered as an importer of the 
following basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)...........  I
Lysergic acid diethylamide (7315)..........  I
Heroin (9200)..............................  I
Cocaine (9041).............................  II
Codeine (9050).............................  II
Hydrocodone (9193).........................  II
Meperidine (9230)..........................  II
Methadone (9250)...........................  II
Morphine (9300)............................  II
------------------------------------------------------------------------


[[Page 33785]]

    The company plans to import these controlled substances for the 
manufacture of reference standards.
    Any bulk manufacturer who is presently, or is applying to be, 
registered with DEA to manufacture such basic classes of controlled 
substances may file comments or objections to the issuance of the 
proposed registration and may, at the same time, file a written request 
for a hearing on such application pursuant to 21 CFR 1301.43, and in 
such form as prescribed by 21 CFR 1316.47.
    Any such written comments or objections should be addressed, in 
quintuplicate, to Drug Enforcement Administration, Office of Diversion 
Control, Federal Register Representative (ODL), 8701 Morrissette Drive, 
Springfield, Virginia 22152; and must be filed no later than July 11, 
2011.
    This procedure is to be conducted simultaneously with, and 
independent of, the procedures described in 21 CFR 1301.34(b), (c), 
(d), (e), and (f). As noted in a previous notice published in the 
Federal Register on September 23, 1975, 40 FR 43745-46, all applicants 
for registration to import a basic class of any controlled substance in 
Schedule I or II are, and will continue to be, required to demonstrate 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, that the requirements for such 
registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 
1301.34(b), (c), (d), (e), and (f) are satisfied.

    Dated: June 1, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2011-14255 Filed 6-8-11; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.